Skip to main content

Table 1 Patient and treatment characteristics

From: Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer

Characteristics Patients, n = 61
Median age (range) 65 (40–84)
Sex  
Male 29 (48%)
Female 32 (53%)
Race  
White 39 (64%)
Black 21 (34%)
Other 1 (2%)
Histology  
Adenocarcinoma 30 (49%)
Squamous 18 (30%)
NSCLC NOS* 13 (21%)
T Stage  
T1 9 (15%)
T2 20 (33%)
T3 11 (18%)
T4 19 (31%)
Tx 2 (3%)
N Stage  
N0 1 (2%)
N2 32 (52%)
N3 28 (46%)
AJCC Stage (V.7)  
IIIA 22 (36%)
IIIB 39 (64%)
Radiation Technique  
3-D Conformal 45 (74%)
IMRT 9 (15%)
3-D Conformal & IMRT 7 (11%)
Radiation Dose, median (range) 66 Gy (39.6-74 Gy)
Treatment Planning Margins, median (range)  
GTV to CTV expansion 0.5 cm (0–1 cm)
CTV to PTV expansion 1 cm (0.3-2.5 cm)
Use of daily On-board Imaging (OBI) 24 (39%)
Concurrent Chemotherapy 55 (90%)
  1. *NSCLC NOS- non-small cell carcinoma not otherwise specified.